HPV prevalence in Colombian women with cervical cancer: implications for vaccination in a developing country

Item

http://www.wikidata.org/entity/Q33568522

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

HPV prevalence in Colombian wo ...... nation in a developing country

@ast

HPV prevalence in Colombian wo ...... nation in a developing country

@en

HPV prevalence in Colombian wo ...... ation in a developing country.

@nl

type

Item

label

HPV prevalence in Colombian wo ...... nation in a developing country

@ast

HPV prevalence in Colombian wo ...... nation in a developing country

@en

HPV prevalence in Colombian wo ...... ation in a developing country.

@nl

prefLabel

HPV prevalence in Colombian wo ...... nation in a developing country

@ast

HPV prevalence in Colombian wo ...... nation in a developing country

@en

HPV prevalence in Colombian wo ...... ation in a developing country.

@nl

P1476

HPV prevalence in Colombian wo ...... nation in a developing country

@en

P2093

Gilberto Martínez

http://www.w3.org/2001/XMLSchema#string

Juan-Carlos Mejía

http://www.w3.org/2001/XMLSchema#string

Mónica Molano

http://www.w3.org/2001/XMLSchema#string

Oscar Gamboa

http://www.w3.org/2001/XMLSchema#string

Raúl Murillo

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2002

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia

Epidemiologic classification of human papillomavirus types associated with cervical cancer

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes.

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.

Prevalence of high-risk human papillomavirus types in Mexican women with cervical intraepithelial neoplasia and invasive carcinoma.

A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings

P304

653598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2009/653598

http://www.w3.org/2001/XMLSchema#string

P478

2009

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40851205

http://www.w3.org/2001/XMLSchema#string

P698

20052389

http://www.w3.org/2001/XMLSchema#string

P932

2801009

http://www.w3.org/2001/XMLSchema#string